BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22729944)

  • 1. The parasitic helminth product ES-62 suppresses pathogenesis in collagen-induced arthritis by targeting the interleukin-17-producing cellular network at multiple sites.
    Pineda MA; McGrath MA; Smith PC; Al-Riyami L; Rzepecka J; Gracie JA; Harnett W; Harnett MM
    Arthritis Rheum; 2012 Oct; 64(10):3168-78. PubMed ID: 22729944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
    Ito Y; Usui T; Kobayashi S; Iguchi-Hashimoto M; Ito H; Yoshitomi H; Nakamura T; Shimizu M; Kawabata D; Yukawa N; Hashimoto M; Sakaguchi N; Sakaguchi S; Yoshifuji H; Nojima T; Ohmura K; Fujii T; Mimori T
    Arthritis Rheum; 2009 Aug; 60(8):2294-303. PubMed ID: 19644886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against collagen-induced arthritis in mice afforded by the parasitic worm product, ES-62, is associated with restoration of the levels of interleukin-10-producing B cells and reduced plasma cell infiltration of the joints.
    Rodgers DT; Pineda MA; McGrath MA; Al-Riyami L; Harnett W; Harnett MM
    Immunology; 2014 Mar; 141(3):457-66. PubMed ID: 24708419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ES-62 protects against collagen-induced arthritis by resetting interleukin-22 toward resolution of inflammation in the joints.
    Pineda MA; Rodgers DT; Al-Riyami L; Harnett W; Harnett MM
    Arthritis Rheumatol; 2014 Jun; 66(6):1492-503. PubMed ID: 24497523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of type-II collagen suppresses IL-17-associated RANKL expression of CD4+ T cells in collagen-induced arthritis.
    Ju JH; Cho ML; Jhun JY; Park MJ; Oh HJ; Min SY; Cho YG; Hwang SY; Kwok SK; Seo SH; Yoon CH; Park SH; Kim HY
    Immunol Lett; 2008 Apr; 117(1):16-25. PubMed ID: 18242716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis.
    Sheibanie AF; Khayrullina T; Safadi FF; Ganea D
    Arthritis Rheum; 2007 Aug; 56(8):2608-19. PubMed ID: 17665454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist.
    Lamacchia C; Palmer G; Seemayer CA; Talabot-Ayer D; Gabay C
    Arthritis Rheum; 2010 Feb; 62(2):452-62. PubMed ID: 20112392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis.
    Kwok SK; Cho ML; Park MK; Oh HJ; Park JS; Her YM; Lee SY; Youn J; Ju JH; Park KS; Kim SI; Kim HY; Park SH
    Arthritis Rheum; 2012 Mar; 64(3):740-51. PubMed ID: 21968544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis.
    van Hamburg JP; Mus AM; de Bruijn MJ; de Vogel L; Boon L; Cornelissen F; Asmawidjaja P; Hendriks RW; Lubberts E
    Arthritis Rheum; 2009 Mar; 60(3):750-9. PubMed ID: 19248112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-17 as a molecular target in immune-mediated arthritis: immunoregulatory properties of genetically modified murine dendritic cells that secrete interleukin-4.
    Sarkar S; Tesmer LA; Hindnavis V; Endres JL; Fox DA
    Arthritis Rheum; 2007 Jan; 56(1):89-100. PubMed ID: 17195211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
    Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
    Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of T-bet gene regulates murine autoimmune arthritis.
    Kondo Y; Iizuka M; Wakamatsu E; Yao Z; Tahara M; Tsuboi H; Sugihara M; Hayashi T; Yoh K; Takahashi S; Matsumoto I; Sumida T
    Arthritis Rheum; 2012 Jan; 64(1):162-72. PubMed ID: 21905017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators.
    Hartgring SA; Willis CR; Alcorn D; Nelson LJ; Bijlsma JW; Lafeber FP; van Roon JA
    Arthritis Rheum; 2010 Sep; 62(9):2716-25. PubMed ID: 20499386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
    Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin octapeptide significantly suppresses collagen-induced arthritis in mice by inhibiting Th17 polarization primed by dendritic cells.
    Li Q; Han D; Cong B; Shan B; Zhang J; Chen H; Ma C; Liyanage SS
    Cell Immunol; 2011; 272(1):53-60. PubMed ID: 22004797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of interleukin-17 receptor a signaling prevents autoimmune inflammation of the joint and leads to a Th2-like phenotype in collagen-induced arthritis.
    Corneth OB; Mus AM; Asmawidjaja PS; Klein Wolterink RG; van Nimwegen M; Brem MD; Hofman Y; Hendriks RW; Lubberts E
    Arthritis Rheumatol; 2014 Feb; 66(2):340-9. PubMed ID: 24504806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of a novel tylophorine analog, NK-007, on collagen-induced arthritis through suppressing tumor necrosis factor α production and Th17 cell differentiation.
    Wen T; Li Y; Wu M; Sun X; Bao X; Lin Y; Hao J; Han L; Cao G; Wang Z; Liu Y; Wu Z; Hong Z; Wang P; Zhao L; Li Z; Wang Q; Yin Z
    Arthritis Rheum; 2012 Sep; 64(9):2896-906. PubMed ID: 22576707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17.
    Chu CQ; Swart D; Alcorn D; Tocker J; Elkon KB
    Arthritis Rheum; 2007 Apr; 56(4):1145-51. PubMed ID: 17393396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.